Emirates deploys latest Boeing aircraft to Riyadh & Kuwait

Emirates will be operating its latest Boeing 777-300ER aircraft fitted with the ‘game changer’ first class suites from Dubai to Riyadh and Kuwait.
Updated 21 April 2019

Emirates deploys latest Boeing aircraft to Riyadh & Kuwait

In a move to offer a range of experiences and greater choice for its customers traveling for business and leisure, Emirates will be operating its latest Boeing 777-300ER aircraft fitted with the “game changer” first class suites from Dubai to Riyadh starting from April 16 and Kuwait starting from June 1.
Adil Al-Ghaith, senior vice president commercial operations Gulf, Middle East and Iran, said: “Saudi Arabia and Kuwait will be the first countries in the Middle East and GCC to be served by the latest Emirates Boeing 777 aircraft featuring fully enclosed private suites inspired by luxury automaker Mercedes-Benz.
“Deploying the newest Boeing 777 to both Riyadh and Kuwait will cater to the significant premium demand we see on these routes, and is in line with our commitment to provide our customers across all classes with outstanding service and industry-leading onboard products for a better flying experience.
“The unique first class suites onboard the Boeing 777 will offer our premium passengers unparalleled privacy, comfort and luxury, with experiences tailored to their individual needs,” said the official.
Travelers to/from Saudi Arabia can experience the new Boeing 777 product on flights EK 819 and EK 820.
The new Boeing 777 aircraft will begin operating the route five times a week, and from June 1 will begin flying on a daily basis. Customers flying on the latest Emirates Boeing 777 are then able to enjoy seamless connections via Dubai to London Heathrow, Paris, Madrid, New York JFK, Hyderabad, Barcelona, Los Angeles, Geneva and Amsterdam.
Emirates will be expanding its premium Boeing 777 experience between Kuwait and Dubai on EK 855 and EK 856. The service will operate daily to Kuwait. The Dubai-Kuwait route was ranked one of the “World’s 20 Busiest Routes,” according to OAG Aviation, and is the busiest route across the Middle East and North Africa.
Emirates Boeing 777 private suites feature floor-to-ceiling sliding doors and ultra-modern design features against cool grey colorscapes. Offering up to 40 square feet of personal space each, the fully enclosed private suites are laid out in a 1-1-1 configuration, for a total of six suites.
The new suites include seats that recline into a fully flat bed that maneuvers into multiple positions and can be placed in a “zero-gravity” state inspired by NASA technology, for a feeling of weightlessness while flying. Passengers can also choose from a multitude of lighting colors and adjust the temperature of their suites. The industry’s first virtual windows can be experienced by customers seated in suites located in the middle aisle. The virtual windows project a view from outside the aircraft using real time fiber-optic camera technology. Emirates also provides binoculars to customers who want to explore the vistas and cities below during their journey.


Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

Updated 27 May 2020

Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

  • Trials are being led locally as an essential means to verify the safety and effectiveness of a new drug
  • Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic

RIYADH: Clinical trials in Saudi Arabia could speed up the adoption of new drugs locally, a pharmaceutical executive has told Arab News.

“Clinical trials have two very big benefits for the Kingdom. Firstly, they provide data in the long run with respect to safety and efficacy, catered specifically to the Saudi population. Secondly, they impact local investment and build healthcare capabilities,” Managing Director of Eli Lilly Dimitri Livadas said..

Lividas further explained that the clinical trial phase of any new treatment is crucial as it represents the stage between the adoption or rejection of a drug. Working with the Ministry of Health and with a presence in the Kingdom for 42 years, the pharmaceutical company began research trials in the country in 2016, consisting of five pre-marketing activities and three monitoring studies for post-marketing.

Lividas added that the trials are being led locally as an essential means to verify the safety and effectiveness of a new drug before it is put to the market and introduced to patients. The majority of these are focused on diabetes, oncology, immunology, and osteoporosis.

“We genuinely believe that our future is here in Saudi Arabia. We continue to make great progress in having a commercial organization in the Kingdom that is fully staffed by Saudi nationals,” said Lividas.

As a biopharmaceutical company, Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic. It recently announced partnership with AbCellera to develop a treatment for the virus and aims to enter into clinical trials this year.

“I salute the Saudi authorities for their strong measures to contain the spread of COVID-19. I think it is an example to the world on how to do this. I would like to also express my gratitude toward all healthcare professionals who are currently on the frontlines, risking their own health to help others," Lividas said.